Position in TLRY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,327
-$1,409 QoQ
Shares Held
741
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#133
of 235 holders
Holding Since
Mar 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Derivatives in TLRY
reported options exposure · as of Jun 30, 2026CallValue
$106,862
CallShares
23,800
PutValue
$44,451
PutShares
9,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Belvedere Trading LLC holds $3,327 across 1 Drug Manufacturers - Specialty & Generic name. TLRY ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TLRY |
Tilray Brands, Inc.
This page
|
741 | $3,327 |
All Filings in TLRY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,327 | 741 | Shares | Sole | 2026-07-31 | |
| 2026-06-30 | $44,451 | 9,900 | Put | Sole | 2026-07-31 | |
| 2026-06-30 | $106,862 | 23,800 | Call | Sole | 2026-07-31 | |
| 2026-03-31 | $158,515 | 24,500 | Call | Sole | 2026-05-12 | |
| 2026-03-31 | $4,736 | 732 | Shares | Sole | 2026-05-12 | |
| 2026-03-31 | $64,053 | 9,900 | Put | Sole | 2026-05-12 | |
| 2025-12-31 | $68,248 | 7,558 | Shares | Sole | 2026-02-10 | |
| 2025-12-31 | $928,284 | 102,800 | Put | Sole | 2026-02-10 | |
| 2025-12-31 | $271,803 | 30,100 | Call | Sole | 2026-02-10 | |
| 2022-03-31 | $621,600 | 80,000 | Put | Sole | 2022-04-20 | |
| No filing history on record for this holder in this stock. | ||||||